Emergent BioSolutions Inc.
EBS · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $100 | $112 | $643 | $576 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $155 | $191 | $159 | $279 |
| Inventory | $312 | $329 | $351 | $345 |
| Other Curr. Assets | $33 | $48 | $58 | $70 |
| Total Curr. Assets | $599 | $680 | $1,210 | $1,270 |
| Property Plant & Equip (Net) | $271 | $399 | $837 | $828 |
| Goodwill | $0 | $0 | $218 | $225 |
| Intangibles | $502 | $567 | $729 | $605 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $19 | $178 | $172 | $30 |
| Total NC Assets | $791 | $1,144 | $1,956 | $1,688 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,390 | $1,823 | $3,166 | $2,958 |
| Liabilities | – | – | – | – |
| Payables | $61 | $112 | $104 | $129 |
| Short-Term Debt | $3 | $414 | $963 | $37 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $26 | $12 |
| Other Curr. Liab. | $99 | $125 | $136 | $196 |
| Total Curr. Liab. | $162 | $651 | $1,229 | $374 |
| LT Debt | $673 | $447 | $463 | $834 |
| Deferred Rev, NC | $0 | $0 | $0 | $5 |
| Deferred Tax Liab, NC | $42 | $0 | $60 | $93 |
| Other NC Liab. | $29 | $76 | $27 | $41 |
| Total NC Liab. | $745 | $523 | $550 | $972 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $10 | $0 | $15 | $24 |
| Total Liabilities | $907 | $1,174 | $1,779 | $1,346 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$212 | -$22 | $739 | $950 |
| AOCI | -$5 | -$6 | $3 | -$16 |
| Other Equity | $700 | $677 | $646 | $677 |
| Total Equity | $483 | $649 | $1,388 | $1,612 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,390 | $1,823 | $3,166 | $2,958 |
| Net Debt | $577 | $749 | $784 | $295 |